Literature DB >> 20816267

Management of arterial blood pressure in acute ischemic and hemorrhagic stroke.

Sara Hocker1, Sarkis Morales-Vidal, Michael J Schneck.   

Abstract

It is essential to control arterial blood pressure (BP) in both hemorrhagic and ischemic stroke patients to decrease morbidity following an acute event and decrease the long-term risk of stroke recurrence. Pathophysiology of BP control is dependent on understanding key relationships of cerebral blood flow and cerebral perfusion pressure. In the long term, hypertensive control decreases the rate of incident and recurrent hemorrhagic and ischemic stroke. In the acute setting, neither when to start antihypertensive medication nor the optimal BP target goals for short- and long-term control are well defined. There are several different drug classes available for BP control, with considerable debate as to which drugs are preferred for stroke patients. Medication selection and target BP depend on individual patient characteristics, including type of stroke, medical comorbidities, and timing of interventions in the context of the acute or postacute phases of stroke. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20816267     DOI: 10.1016/j.ncl.2010.03.021

Source DB:  PubMed          Journal:  Neurol Clin        ISSN: 0733-8619            Impact factor:   3.806


  3 in total

1.  Clinical factors in patients with ischemic versus hemorrhagic stroke in East China.

Authors:  Jing Zhang; Yao Wang; Gan-Nan Wang; Hao Sun; Tao Sun; Jian-Quan Shi; Hang Xiao; Jin-Song Zhang
Journal:  World J Emerg Med       Date:  2011

2.  A Reasonable Blood Pressure Level for Good Clinical Outcome After the Acute Phase of Ischemic Stroke.

Authors:  Niu Ji; Pin Meng; Na Liu; Bingchao Xu; Guanghui Zhang; Xinyu Zhou; Mingli He
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-09-23       Impact factor: 3.738

3.  Finite element analysis of mechanics of neovessels with intraplaque hemorrhage in carotid atherosclerosis.

Authors:  Jinqiu Lu; Wanying Duan; Aike Qiao
Journal:  Biomed Eng Online       Date:  2015-01-09       Impact factor: 2.819

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.